Hypertensive disorders of pregnancy, maternal cardiovascular disease mortality and the role of familial predisposition: a Norwegian population-based sibling-comparison, sibling-spillover and negative-control cohort study
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwaf257 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Aditi Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Siblings, Cardiovascular Diseases, Hypertension, Pregnancy-Induced, Genetic Predisposition to Disease. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, University of Bergen, European Union's Horizon 2020 Research and Innovation Programme, European Union’s Horizon 2020 Research and Innovation Programme.
Abstract (Originalsprache)
Hypertensive disorders of pregnancy (HDP) are associated with increased maternal cardiovascular disease (CVD) mortality, with risks varying by HDP subtypes and subsequent pregnancy outcomes. The contribution of shared familial factors given this heterogeneity is unclear. We conducted a population-based study using Norwegian registries (1967-2020) including 1 106 658 women with complete pregnancy histories, of whom 628 345 had at least one full sibling. Women with HDP were classified into low-risk (gestational hypertension or term pre-eclampsia followed by no HDPs) and high-risk (all other patterns) trajectories. CVD mortality before age 70 was assessed using population-level and sibling-based models: sibling-comparison (discordant-sisters), sibling-spillover (by sister’s HDP history), and negative-control models (by sister-in-law’s HDP history). CVD mortality among women with HDP varied by trajectory (population-level adjusted hazard ratios [aHR]low-risk 1.03 [95% confidence intervals, 0.89-1.20]; aHRhigh-risk 1.89 [1.74-2.06]). These differences persisted when compared to sisters without HDP (sibling-comparison aHRlow-risk 0.66 [0.44-1.01]; aHRhigh-risk 1.51 [1.16-1.97]). Women without HDP had slightly elevated CVD mortality if sisters had HDP (sibling-spillover aHRlow-risk 1.28 [1.03-1.60]; aHRhigh-risk 1.25 [1.06-1.49]), but not if sisters-in-law had HDP (negative-control aHRlow-risk 1.10 [0.85-1.40]; aHRhigh-risk 1.01 [0.83-1.22]). Individual-specific factors drive the CVD mortality heterogeneity among women with HDP. Shared familial factors modestly elevate CVD mortality in women without HDP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
- Center for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
ORCID-Profile: Aditi Singh, Sage Wyatt, Liv Grimstvedt Kvalvik, Rolv Skjærven
Förderung
- Faculty of Medicine, University of Bergen
- European Union's Horizon 2020 Research and Innovation Programme
- European Union’s Horizon 2020 Research and Innovation Programme
Zitieren
APA
Singh, A., Wyatt, S., Kvalvik, L. G., & Skjærven, R. (2025). Hypertensive disorders of pregnancy, maternal cardiovascular disease mortality and the role of familial predisposition: a Norwegian population-based sibling-comparison, sibling-spillover and negative-control cohort study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf257
Vancouver
Singh A, Wyatt S, Kvalvik LG, Skjærven R. Hypertensive disorders of pregnancy, maternal cardiovascular disease mortality and the role of familial predisposition: a Norwegian population-based sibling-comparison, sibling-spillover and negative-control cohort study. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf257
BibTeX
@article{Singh2025,
author = {Singh, Aditi and Wyatt, Sage and Kvalvik, Liv Grimstvedt and Skjærven, Rolv},
title = {Hypertensive disorders of pregnancy, maternal cardiovascular disease mortality and the role of familial predisposition: a Norwegian population-based sibling-comparison, sibling-spillover and negative-control cohort study},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwaf257}
}
EUVIMED